Guerbet
GBT | XPAR
Overview
Corporate Details
- ISIN(s):
- FR0000032526 (+3 more)
- LEI:
- 969500WV1U1WQ059L135
- Country:
- France
- Address:
- 15 RUE DES VANESSES, 93420 VILLEPINTE
- Website:
- https://www.guerbet.com
- Sector:
- Health Care
- Industry:
- Pharmaceuticals
Description
At Guerbet, we build lasting relationships so that we enable people to live better. This is our Purpose. We place human cooperation at the heart of our relationships and actions. We are a leader in medical imaging worldwide, offering a wide range of pharmaceutical products, medical devices, digital and AI solutions for diagnostic and interventional imaging. A pioneer since 95 years in the field of contrast media, we are a team of over 2,600 people globally, continuously innovating with 10% of revenue dedicated to Research & Development across four centers in France, Israel and the United States.
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-05-16 17:30 |
Declaration of Voting Results & Voting Rights Announcements
GUERBET : Nombre d'actions et de droits de vote composant le capital de la soci…
|
French | 96.3 KB | |
| 2025-04-24 17:45 |
Earnings Release
Guerbet: Q1 2025 revenue
|
English | 473.1 KB | |
| 2025-04-24 17:45 |
Earnings Release
GUERBET: Chiffre d’affaires du 1er trimestre 2025
|
French | 478.4 KB | |
| 2025-04-11 17:45 |
Declaration of Voting Results & Voting Rights Announcements
GUERBET : Nombre d'actions et de droits de vote composant le capital de la soci…
|
French | 96.3 KB | |
| 2025-04-03 15:20 |
Report Publication Announcement
GUERBET : Mise à disposition du Document d’enregistrement universel 2024
|
French | 147.4 KB | |
| 2025-04-03 12:24 |
Annual Report (ESEF)
GUERBET - DEU 2024
|
French | 31.0 MB | |
| 2025-03-26 17:45 |
Earnings Release
GUERBET : Résultats annuels 2024.
|
French | 298.5 KB | |
| 2025-03-26 17:45 |
Earnings Release
GUERBET : 2024 full-year results.
|
English | 241.1 KB | |
| 2025-03-18 17:45 |
Regulatory News Service
Guerbet x Intrasense : DUOncoTM Bone : premier algorithme d’IA marqué CE pour l…
|
French | 700.9 KB | |
| 2025-03-18 17:45 |
Regulatory News Service
DUOncoTM Bone : First CE marked IA algorithm for automatic detection of bone le…
|
English | 636.4 KB | |
| 2025-03-13 17:45 |
Declaration of Voting Results & Voting Rights Announcements
GUERBET : Nombre d'actions et de droits de vote composant le capital de la soci…
|
French | 96.3 KB | |
| 2025-01-17 18:00 |
Capital/Financing Update
GUERBET : Bilan semestriel du contrat de liquidité
|
French | 115.7 KB | |
| 2025-01-14 18:00 |
Declaration of Voting Results & Voting Rights Announcements
GUERBET : Nombre d'actions et de droits de vote composant le capital de la soci…
|
French | 96.0 KB | |
| 2025-01-13 18:00 |
Inside Information Statement
Correction: GUERBET : Calendrier financier de l'exercice 2025
|
French | 177.2 KB | |
| 2025-01-13 18:00 |
Inside Information Statement
Correction: GUERBET : Financial agenda for 2025
|
English | 135.7 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-08-19 | N/A | Other | Buy | 142 | 4,989.31 EUR |
| 2024-08-15 | N/A | Other | Buy | 195 | 6,678.75 EUR |
| 2024-08-12 | N/A | Other | Buy | 1,000 | 34,350.00 EUR |
| 2024-04-18 | N/A | Other | Sell | 550 | 17,699.00 EUR |
| 2023-11-30 | N/A | Other | Sell | 700 | 12,684.00 EUR |
| 2023-11-03 | N/A | Other | Buy | 1 | 17.92 EUR |
| 2023-10-30 | N/A | Other | Buy | 1,000 | 17,000.00 EUR |
| 2023-10-25 | N/A | Other | Buy | 1,000 | 16,800.00 EUR |
| 2023-10-24 | N/A | Other | Buy | 1,000 | 16,460.90 EUR |
| 2023-05-04 | N/A | Other | Buy | 300 | 4,938.00 EUR |
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
ABIVAX | France | ABVX | |
|
Addex Therapeutics Ltd | Switzerland | ADXN | |
|
AegirBio AB | Sweden | AEGIR | |
|
AGRONOMICS LIMITED | Isle of Man | ANIC | |
|
AIREA PLC | United Kingdom | AIEA | |
|
Alkaloid AD | North Macedonia | ALK | |
| Alma Yesodot Ltd. | Israel | KVSR | ||
|
Antibiotice S.A. | Romania | ATB | |
|
Aran Research & Development (1982) Ltd. | Israel | ARAN | |
|
Asarina Pharma AB | Sweden | ASAP |